It has been hypothesized that the selective deficit of the canonical TGF-β1/Smad pathway in AD may impair the cross-talk between astrocytes and microglia, subsequently leading to microglia-mediated neurodegeneration [136]. Here, TGFB1 is linked to Alzheimer disease.